RPRX
Royalty Pharma plc
Stock
$57.16−0.47 (−0.82%)Close Oct 2, 2026
- Research and development, 2025
- $452M
- YoY, 2025
- +22,500.0%
- 5-year CAGR
- +76.6%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $452M | +22,500.0% |
| 2024 | $2.0M | −96.2% |
| 2023 | $52M | −70.6% |
| 2022 | $177M | −11.5% |
| 2021 | $200M | +661.1% |
| 2020 | $26M | −68.3% |
| 2019 | $83M | −78.9% |
| 2018 | $393M | — |